UiPath (PATH) Stock Jumps 10.4%: Will It Continue to Soar?

Zacks
01-29

UiPath (PATH) shares soared 10.4% in the last trading session to close at $15.19. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 8% gain over the past four weeks.

The stock is benefiting from strong customer enthusiasm for PATH’s agentic automation vision, unveiled at FORWARD, reinforcing the company’s leadership in AI-driven automation and boosting investor confidence.

This enterprise automation software developer is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of -13.6%. Revenues are expected to be $424.75 million, up 4.8% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For UiPath, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on PATH going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

UiPath is part of the Zacks Technology Services industry. V2X (VVX), another stock in the same industry, closed the last trading session 3% lower at $51.98. VVX has returned 11.1% in the past month.

For V2X , the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.13. This represents a change of -7.4% from what the company reported a year ago. V2X currently has a Zacks Rank of #3 (Hold).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UiPath, Inc. (PATH) : Free Stock Analysis Report

V2X, Inc. (VVX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10